These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12064994)

  • 1. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin.
    Grabs AJ; Lord RS
    Med J Aust; 2002 Jun; 176(11):563. PubMed ID: 12064994
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment failure due to methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to vancomycin.
    Ward PB; Johnson PD; Grabsch EA; Mayall BC; Grayson ML
    Med J Aust; 2001 Nov; 175(9):480-3. PubMed ID: 11758077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Vancomycin Susceptibility, MRSA and Treatment Failure in Pediatric Staphylococcus aureus Bloodstream Infections.
    Canty E; Carnahan B; Curley T; Anususinha E; Hamdy RF; Ericson JE
    Pediatr Infect Dis J; 2021 May; 40(5):429-433. PubMed ID: 33196562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
    Sakoulas G; Moellering RC
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
    Appelbaum PC
    Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vancomycin MIC susceptibility testing of methicillin-susceptible and methicillin-resistant Staphylococcus aureus isolates: a comparison between Etest® and an automated testing method.
    Bland CM; Porr WH; Davis KA; Mansell KB
    South Med J; 2010 Nov; 103(11):1124-8. PubMed ID: 20890258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaches to serious methicillin-resistant Staphylococcus aureus infections with decreased susceptibility to vancomycin: clinical significance and options for management.
    Lewis JS; Ellis MW
    Curr Opin Infect Dis; 2007 Dec; 20(6):568-73. PubMed ID: 17975405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections.
    Micek ST
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S184-90. PubMed ID: 17712745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence in Asian countries of Staphylococcus aureus with reduced susceptibility to vancomycin.
    Song JH; Hiramatsu K; Suh JY; Ko KS; Ito T; Kapi M; Kiem S; Kim YS; Oh WS; Peck KR; Lee NY;
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4926-8. PubMed ID: 15561884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of mecA gene and borderline oxacillin resistant Staphylococcus aureus in nosocomial acquired methicillin resistance Staphylococcus aureus infections.
    Khorvash F; Mostafavizadeh K; Mobasherizadeh S
    Pak J Biol Sci; 2008 May; 11(9):1282-5. PubMed ID: 18819540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical relevance of hetero-VRSA in surgical infections].
    Okii K; Takesue Y; Yokoyama T
    Nihon Rinsho; 2001 Apr; 59(4):728-32. PubMed ID: 11304997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil.
    Panesso D; Planet PJ; Diaz L; Hugonnet JE; Tran TT; Narechania A; Munita JM; Rincon S; Carvajal LP; Reyes J; Londoño A; Smith H; Sebra R; Deikus G; Weinstock GM; Murray BE; Rossi F; Arthur M; Arias CA
    Emerg Infect Dis; 2015 Oct; 21(10):1844-8. PubMed ID: 26402569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremia.
    Mascitti KB; Edelstein PH; Fishman NO; Morales KH; Baltus AJ; Lautenbach E
    Infect Control Hosp Epidemiol; 2012 Feb; 33(2):160-6. PubMed ID: 22227985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The emergence of Staphylococcus aureus with reduced susceptibility to vancomycin in Japan.
    Hiramatsu K
    Am J Med; 1998 May; 104(5A):7S-10S. PubMed ID: 9684652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacteremia due to methicillin-resistant Staphylococcus aureus (MRSA)].
    Funada H
    Nihon Rinsho; 1992 May; 50(5):1081-6. PubMed ID: 1507431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Dutch MRSA policy should be retained].
    Vlaminckx BJ; Troelstra A; van der Bruggen T
    Ned Tijdschr Geneeskd; 2006 Aug; 150(34):1884. PubMed ID: 16970011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolonged vancomycin administration on methicillin-resistant Staphylococcus aureus (MRSA) in a patient with recurrent bacteraemia.
    Sakoulas G; Gold HS; Cohen RA; Venkataraman L; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 2006 Apr; 57(4):699-704. PubMed ID: 16464892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, epidemiological, and laboratory aspects of methicillin-resistant Staphylococcus aureus (MRSA) infections.
    Palavecino E
    Methods Mol Biol; 2007; 391():1-19. PubMed ID: 18025665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key considerations in the treatment of complicated staphylococcal infections.
    Jones RN
    Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A; Marco F; Martínez JA; Pisos E; Almela M; Dimova VP; Alamo D; Ortega M; Lopez J; Mensa J
    Clin Infect Dis; 2008 Jan; 46(2):193-200. PubMed ID: 18171250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.